Learn more about IMRIS neurosurgical imaging products at booth #2013
WINNIPEG, April 22, 2013 /PRNewswire/ - IMRIS, Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that it will exhibit its novel intraoperative CT solution with state-of-the-art imaging that is currently under development at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting, April 27-May 1, in New Orleans, LA.
Attendees are invited to visit the IMRIS booth (#2013) in the exhibition hall to learn more about its integrated VISIUS ® iMRI and VISIUS iCT products. (VISIUS iCT is pending US FDA 510(k) approval and is not available for sale in any market.)
Like the VISIUS ® Surgical Theatre with iMRI, the VISIUS iCT will move on-demand using ceiling-mounted rails for effortless access in the OR so no patient transport is required for imaging. The multifunctional environment eliminates space compromises of floor rail or wheeled portable systems to optimize workflow and may improve surgical outcomes. Developed for cranial and spinal surgery, the system is also intended to provide physicians with advanced image quality with access to a full range of software applications for intelligent dosing.The IMRIS comprehensive and interactive AANS booth will also have on display its latest neurosurgical advancements in robotics with the SYMBIS™ Surgical System, operating room tables, head fixation devices and imaging coils. (The SYMBIS Surgical System is FDA 510(k) pending and not available for sale in any market.) The central theme of the AANS 2013 educational sessions relates to advancing patient safety. Scheduled presentations by faculty members will be an opportunity to demonstrate the current and future impact of intraoperative MRI and CT imaging in cranial and spinal neurosurgery. Clinical studies show that transporting patients for intraoperative imaging - even a short distance - poses risks related to the movement of monitoring equipment, cardiac and respiratory issues, and workflow and positioning ramifications.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts